Rosuvastatin, a statin medication, treats high cholesterol and triglycerides while reducing cardiovascular risks like heart attacks and strokes. It functions as a competitive inhibitor of HMG-CoA reductase, the liver enzyme crucial for cholesterol production, thereby lowering LDL ("bad" cholesterol) and VLDL levels while modestly raising HDL ("good" cholesterol). Rosuvastatin proves highly potent among statins, with clinical studies demonstrating LDL reductions of 45.8% to 54.6% at doses of 10-40 mg daily, alongside benefits like anti-inflammatory effects on endothelium and nitric oxide modulation. Available orally in tablet form, it supports primary and secondary prevention in adults and certain children with familial hypercholesterolemia, often combined with diet and exercise. Hepatic uptake of LDL increases due to upregulated receptors, making it a cornerstone in dyslipidemia management.